ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

ClinicalTrials.gov ID: NCT03565887

Public ClinicalTrials.gov record NCT03565887. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis

Study identification

NCT ID
NCT03565887
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
RVL Pharmaceuticals, Inc.
Industry
Enrollment
164 participants

Conditions and interventions

Conditions

Interventions

  • RVL-1201 Drug
  • Vehicle ophthalmic solution Other

Drug · Other

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2018
Primary completion
Apr 10, 2019
Completion
Apr 21, 2019
Last update posted
Sep 15, 2020

2018 – 2019

United States locations

U.S. sites
36
U.S. states
14
U.S. cities
33
Facility City State ZIP Site status
Barnet, Dulany Perkins Phoenix Arizona 85016
Orange County Ophthalmology Garden Grove California 92843
North Valley Eye Mission Hills California 941345
Eye Research Foundation Newport Beach California 92663
Pendelton Eye Center Oceanside California 92056
North Bay Eye Associates Petaluma California 94954
Michael Tran Westminster California 92683
Danbury Eye Physicians Danbury Connecticut 06810
Hernando Eye Institute Brooksville Florida 34615
Shettle Eye Research Largo Florida 33773
West Coast Eye Lecanto Florida 34461
Sabal Eye Care Longwood Florida 32779
Maitland Vision Center Maitland Florida 32751
Sarasota Retina Institute Sarasota Florida 34239
East Florida Eye Stuart Florida 34994
Coastal Research Associates Roswell Georgia 30076
Kennar Eye Care Pittsburg Kansas 66762
Heart of America Eye Shawnee Mission Kansas 66204
Seidenberg Protzko Eye Havre de Grace Maryland 21078
Mississippi Eye Ocean Springs Mississippi 39564
Silverstein Eye Kansas City Missouri 64133
Comprehensive Eye Care Washington Missouri 63090
Rochester Ophthalmological Rochester New York 14618
South Shore Eye Wantagh New York 11793
CEENTA Charlotte North Carolina 28210
Cornerstone Eye High Point North Carolina 27262
Quinn, Foster & Assoc. Athens Ohio 45701
Apex Eye Cincinnati Ohio 45243
Apex Eye Cincinnati Ohio 45247
Abrams Eye Center Cleveland Ohio 44115
Nashville vision Associates Nashville Tennessee 37205
Round Rock Eye Austin Texas 78681
Texan Eye / Keystone Austin Texas 78731
Lake Travis Eye Lakeway Texas 78734
R&R Research San Antonio Texas 78229
Medical Center Ophthalmology Assocs - Keystone Research San Antonio Texas 78240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03565887, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2020 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03565887 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →